已收盤 10-10 16:00:00 美东时间
-0.050
-0.37%
今日重点评级关注:Ascendiant Capital:维持PAVmed"买入"评级,目标价从19美元升至20美元;Ascendiant Capital:维持Plus Therapeutics"买入"评级,目标价从20.5美元升至21美元
10-07 15:04
Keefe, Bruyette & Woods analyst Paul Johnson upgrades Kayne Anderson BDC (NYSE:KBDC) from Market Perform to Outperform and maintains the price target from $16.5 to $16.5.
10-07 00:35
Kayne Anderson BDC, Inc. ( ($KBDC) ) has issued an update. On September 9, 2025...
09-11 05:30
-SEC Filing
08-27 05:06
There’s a lot to be optimistic about in the NA sector as 2 analysts just weighe...
08-13 19:10
Kayne Anderson BDC, Inc. ( ($KBDC) ) has provided an update. On August 11, 2025...
08-12 05:18
Kayne Anderson BDC (NYSE:KBDC) declared $0.40/share quarterly dividend, in line with previous. Forward yield 10.55% Payable Oct. 16; for shareholders of record Sept. 30; ex-div Sept. 30. See KBDC Divi...
08-12 04:45
Kayne Anderson BDC (NYSE:KBDC) reported quarterly earnings of $0.40 per share which missed the analyst consensus estimate of $0.41 by 2.44 percent. This is a 21.57 percent decrease over earnings of $0.51 per share from
08-12 04:32
Companies Reporting Before The Bell • Niu Techs (NASDAQ:NIU) is expected to rep...
08-11 16:32
In the preceding three months, 4 analysts have released ratings for Kayne Ander...
07-17 02:00